Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
Descriptor ID |
D003131
|
MeSH Number(s) |
E02.186
|
Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 75 | 75 |
1995 | 0 | 76 | 76 |
1996 | 0 | 71 | 71 |
1997 | 0 | 68 | 68 |
1998 | 1 | 85 | 86 |
1999 | 0 | 90 | 90 |
2000 | 1 | 89 | 90 |
2001 | 2 | 98 | 100 |
2002 | 0 | 82 | 82 |
2003 | 1 | 154 | 155 |
2004 | 1 | 142 | 143 |
2005 | 0 | 149 | 149 |
2006 | 1 | 162 | 163 |
2007 | 2 | 160 | 162 |
2008 | 1 | 165 | 166 |
2009 | 2 | 158 | 160 |
2010 | 2 | 172 | 174 |
2011 | 4 | 141 | 145 |
2012 | 1 | 112 | 113 |
2013 | 6 | 131 | 137 |
2014 | 3 | 119 | 122 |
2015 | 3 | 134 | 137 |
2016 | 7 | 174 | 181 |
2017 | 6 | 154 | 160 |
2018 | 4 | 137 | 141 |
2019 | 8 | 144 | 152 |
2020 | 3 | 128 | 131 |
2021 | 2 | 72 | 74 |
2022 | 0 | 30 | 30 |
2023 | 0 | 41 | 41 |
2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. J Immunother Cancer. 2024 Feb 29; 12(2).
-
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal. Eur J Cancer. 2024 Apr; 201:113972.
-
Pan-cancer proteogenomics characterization of tumor immunity. Cell. 2024 Feb 29; 187(5):1255-1277.e27.
-
ASO Visual Abstract: Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy. Ann Surg Oncol. 2024 02; 31(2):1021-1022.
-
Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer. Curr Treat Options Oncol. 2024 Jan; 25(1):66-83.
-
Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy. Clin Colorectal Cancer. 2024 Mar; 23(1):85-94.
-
Management of limited-stage Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):500-509.
-
Patient Navigation for Timely, Guideline-Adherent Adjuvant Therapy for Head and Neck Cancer: A National Landscape Analysis. J Natl Compr Canc Netw. 2023 12; 21(12):1251-1259.e5.
-
ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Ann Surg Oncol. 2023 12; 30(13):8178-8179.
-
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience. J Urol. 2024 Feb; 211(2):241-255.